ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 218

Social Factors and Racial Disparities in Total Hip Arthroplasty Outcomes

Susan M. Goodman1, Bella Y. Mehta2, Meng Zhang3, Jackie Szymonifka4, Joseph T. Nguyen3, Yuo-Yu Lee3, Mark P. Figgie5, Michael L. Parks5, Shirin A. Dey4, Daisy B. Crego4, Linda A. Russell6, Lisa A. Mandl7 and Anne R. Bass6, 1Medicine, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 2Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine/Mailman School of Public Health, New York, NY, 3Epidemiology and Biostatistics, Hospital for Special Surgery, New York, NY, 4Rheumatology, Hospital for Special Surgery, New York, NY, 5Orthopaedic Surgery, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 6Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 7Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Arthroplasty, health disparities, Health outcome, race/ethnicity and socioeconomic factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Healthcare Disparities in Rheumatology Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:  Socioeconomic factors such as poverty may mediate racial disparities in health outcomes including those of total hip arthroplasty (THA), and confound analyses of differences between blacks and whites.

Methods:  Using data from a large institutional THA registry, we compared pain and function 2 years after surgery between blacks and whites. The census tract variable “percent of the population with Medicaid insurance coverage” was used to measure community deprivation. We used geocoding to link patients to census tracts, built models that incorporated both individual patient and census tract data, and analyzed the interaction between race and percent of population with Medicaid coverage and its association with patient-reported outcomes 2 years after THA. 

Results:  Black patients, comprising 145/4170 (3%) of THA cases, had worse pain and function scores both at baseline and at 2 years after THA compared to whites (Table 1). There was a strong positive correlation between census tract Medicaid coverage and percent living below the poverty line (rho = 0.69; p<0.001). Racial disparities in 2-year WOMAC pain and function were magnified in communities with a high percentage of the population covered by Medicaid (Table 2).  For blacks in these communities, 2-year WOMAC function scores were predicted to be 5.54 points lower (80.42 vs. 85.96) than in blacks from communities with a low prevalence of Medicaid coverage, while scores for whites did not differ between communities. Pain scores were also lower for blacks living in deprived areas, but the difference was not significant.

Conclusion:  WOMAC pain and function 2 years after THA are similar among blacks and whites in communities with little deprivation (measured as percent of the population with Medicaid insurance coverage). WOMAC function at 2 years is worse among blacks in areas of higher deprivation, whereas this poverty gradient does not impact outcomes among whites. 

Table 1: Characteristics of the cohort

Characteristic

Total

White

Black

P-Value

Number of patients      

4170 (100%)

4025 (97%)

145 (3%)

 

Age at surgery (years), mean (SD)

65.29 (11.01)

65.42  (10.98)

61.69 (11.23)

0.0002

Female, n (%)

2311 (55.42%)

2219 (55.13%)

92 (63.45%)

0.048

BMI (kg/m2), mean (SD)

27.75 (5.48)

27.68 (5.44)

29.74 (6.33)

0.0002

Hispanic, n (%)

75 (1.80%)

73 (1.81%)

2 (1.38%)

1.00

One or more comorbidities, n (%)

1013 (24.29%)

956 (23.75%)

57 (39.31%)

<0.0001

College or above, n (%)

2805 (68.35%)

2721 (68.69%)

84 (58.74%)

0.012

Insurance payer, n (%)

Medicaid

Medicare

Other insurance

53 (1.27%)

2317 (55.56%)

1800 (43.17%)

30 (0.75%)

2257 (56.07%)

1738 (43.18%)

23 (15.86%)

60 (41.38%)

62 (42.76%)

<0.0001

ASA Class, n (%)

Missing

I-II

III-IV

2

3387 (81.26%)

781 (18.74%)

2

3279 (81.51%)

744 (18.49%)

0

108 (74.48%)

37 (25.52%)

0.033

Hospital for Special Surgery Expectations Score, mean (SD)

83.30 (16.46)

83.17 (16.52)

86.64 (14.42)

0.043

WOMAC pain at baseline, mean (SD)

53.58 (17.85)

53.84 (17.72)

46.48 (20.04)

<0.0001

WOMAC pain at 2 Years, mean (SD)

93.63 (11.39)

93.81 (11.13)

88.60 (16.39)

<0.0001

Delta WOMAC pain, mean (SD)

 

40.04 (19.14)

39.97 (18.95)

42.15 (23.75)

0.144

WOMAC function at baseline, mean (SD)

49.93 (18.04)

50.19 (18.00)

42.78 (17.80)

<0.0001

WOMAC function at 2 Years, mean (SD)

90.86 (13.21)

85.43 (16.09)

77.80 (22.42)

<0.0001

Delta WOMAC function, mean (SD)

40.93 (19.31)

40.89 (19.12)

41.93 (24.22)

0.351

Percent Below Poverty Level, n (%)

              <10%

              10%-20%

              20%-30%

              30%-40%

              >40%

3363 (80.69%)

626 (15.02%)

102 (2.45%)

51 (1.22%)

26 (0.62%)

3303 (82.10%)

585 (14.54%)

82 (2.04%)

33 (0.82%)

20 (0.50%)

60 (41.38%)

41 (28.28%)

20 (13.79%)

18 (12.41%)

6 (4.14%)

<0.0001

Percent with Medicaid Coverage, n (%)

              <=10%

              10%-20%

              20%-30%

              30%-40%

              >40%

3128 (75.85%)

679 (16.46%)

194 (4.70%)

97 (2.35%)

26 (0.63%)

3086 (76.71%)

644 (16.12%)

167 (4.18%)

77 (1.93%)

20 (0.50%)

42 (32.31%)

35 (26.92%)

27 (20.77%)

20 (15.38%)

6 (4.62%)

<0.0001

Table 2: WOMAC pain and function 2 years after total hip arthroplasty: interaction between race and percent of Medicaid coverage at census-tract level

Percent of Medicaid Coverage at Census-Tract Level

Race

WOMAC Pain at 2 Years*

WOMAC Function at 2 Years**

Estimate (Standard Error)

Est. Difference (Standard Error)

P-Value

Estimate (Standard Error)

Est. Difference (Standard Error)

P-Value

10%

Black

White

88.44 (1.59)

90.43 (1.05)

-1.99 (1.29)

0.12

85.96 (1.78)

87.95 (1.19)

-1.99 (1.44)

0.17

20%

Black

White

87.54 (1.28)

90.13 (1.08)

-2.59 (1.12)

0.02

84.11 (1.43)

87.59 (1.22)

-3.48 (1.26)

0.01

30%

Black

White

86.63 (1.38)

89.82 (1.16)

-3.20 (1.45)

0.03

82.27 (1.49)

87.23 (1.31)

-4.96 (1.60)

0.002

40%

Black

White

85.72 (1.81)

89.52 (1.28)

-3.80 (2.04)

0.06

80.42 (1.93)

86.87 (1.45)

-6.45 (2.24)

0.004

50%

Black

White

84.81 (2.41)

89.21 (1.44)

-4.40 (2.74)

0.11

78.57 (2.56)

86.51 (1.63)

-7.94 (2.99)

0.01

60%

Black

White

83.91 (3.07)

88.91 (1.61)

-5.01 (3.47)

0.15

76.73 (3.28)

86.15 (1.83)

-9.42 (3.78)

0.01

*Estimation based on linear mixed-effect model assessing the effect of interaction between race and percent of Medicaid coverage at census-tract level on WOMAC pain at 2 years after THA, using the following assumptions: WOMAC pain at baseline=53; age at surgery=65;  BMI=28/kg/m2; HSS expectation score=83;  sex=female; comorbidities=0;  insurance=Medicaid;  education=college and above.

** Estimation based on linear mixed-effect model assessing the effect of interaction between race and percent of Medicaid coverage at census-tract level on WOMAC function at 2 years after THA, using the following assumptions: WOMAC function at baseline=49; age at surgery=65;  BMI=28/kg/m2; HSS expectation score=83;  sex=female; comorbidities=0;  insurance=Medicaid;  education=college and above.

 


Disclosure: S. M. Goodman, None; B. Y. Mehta, None; M. Zhang, None; J. Szymonifka, None; J. T. Nguyen, None; Y. Y. Lee, None; M. P. Figgie, Lima, 7,Mekanika, 1; M. L. Parks, Zimmer Biomet, Inc., 5; S. A. Dey, None; D. B. Crego, None; L. A. Russell, None; L. A. Mandl, Boehringer Ingelheim, 2,American College of Physicians, 3,Up To Date, 7; A. R. Bass, Pfizer, 9,Abbot, 9.

To cite this abstract in AMA style:

Goodman SM, Mehta BY, Zhang M, Szymonifka J, Nguyen JT, Lee YY, Figgie MP, Parks ML, Dey SA, Crego DB, Russell LA, Mandl LA, Bass AR. Social Factors and Racial Disparities in Total Hip Arthroplasty Outcomes [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/social-factors-and-racial-disparities-in-total-hip-arthroplasty-outcomes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/social-factors-and-racial-disparities-in-total-hip-arthroplasty-outcomes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology